Maxcyte (MXCT) Income towards Parent Company (2020 - 2026)
Maxcyte (MXCT) posted quarterly Income towards Parent Company of -$4.8 million for Q1 2026, up 53.71% year-over-year from -$3.1 million in Q1 2025, and up 50.5% quarter-over-quarter from -$9.6 million in Q4 2025.
Maxcyte (MXCT) Income towards Parent Company (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Income towards Parent Company for 7 consecutive years, with -$4.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company rose 53.71% year-over-year to -$4.8 million; the TTM figure through Mar 2026 stood at -$39.1 million (up 6.39% YoY), while the FY2025 annual figure was -$35.3 million, down 8.58% from the prior year.
- Income towards Parent Company improved to -$4.8 million in Q1 2026 per MXCT's latest filing, from -$9.6 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$4.8 million in Q1 2026 and bottomed at -$30.8 million in Q3 2022.
- Historically, Income towards Parent Company has averaged -$13.4 million across 5 years, with a median of -$10.6 million in 2024.
- Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 1139.94% — and 2023, when it soared 81.56%.
- Maxcyte's Income towards Parent Company stood at -$28.6 million in 2022, then jumped by 81.56% to -$5.3 million in 2023, then slumped by 100.78% to -$10.6 million in 2024, then rose by 9.45% to -$9.6 million in 2025, then jumped by 50.5% to -$4.8 million in 2026.
- Business Quant data shows MXCT's Income towards Parent Company at -$4.8 million in Q1 2026, -$9.6 million in Q4 2025, and -$12.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.87 Mn |
| Mar 31, 2026 | -4.75 Mn |
| Dec 31, 2025 | -9.60 Mn |
| Sep 30, 2025 | -12.42 Mn |
| Jun 30, 2025 | -12.36 Mn |
| Mar 31, 2025 | -10.26 Mn |
| Dec 31, 2024 | -10.60 Mn |
| Sep 30, 2024 | -11.56 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -9.53 Mn |
| Dec 31, 2023 | -5.28 Mn |
| Sep 30, 2023 | -11.25 Mn |
| Jun 30, 2023 | -10.51 Mn |
| Mar 31, 2023 | -10.88 Mn |
| Dec 31, 2022 | -28.62 Mn |
| Sep 30, 2022 | -30.81 Mn |
| Jun 30, 2022 | -10.04 Mn |
| Mar 31, 2022 | -29.52 Mn |
| Dec 31, 2021 | -4.87 Mn |
| Sep 30, 2021 | -2.49 Mn |